Search for: "Courtenay Brinckerhoff" Results 61 - 80 of 80
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Sep 2011, 5:05 pm by Colin O'Keefe
Develop Your Next Generation of Rainmakers - Dallas, Texas attorney coach Cordell Parvin on the Cordell Parvin Blog The Shrill and the Marginal: The Left's Criticism of the Media - Patrick Maines, President of The Media Institute, at the Institute's Media & Communications Policy Blog When Being First-To-File Is Not Enough - Washington, DC lawyer Courtenay Brinckerhoff of Foley & Lardner on the firm's blog, PharmaPatents [read post]
15 Sep 2011, 4:22 pm by Colin O'Keefe
Today isn't entirely without some commentary on the America Invents Act as we continue to see Foley & Lardner's Courtenay Brinckerhoff cover that topic like the gray clouds blanketing Seattle but, for a change of pace, the biggest story today is the FTC's proposed changes to the Children’s Online Privacy Protection Rule; Nicole Friess and Andy Serwin have the story. [read post]
28 Jul 2011, 4:39 pm by Colin O'Keefe
- Dallas non-compete lawyer Rob Radcliff on his Smooth Transitions Law Blog FiOS case update: trial nears conclusion, pre-suit damages ruling issued - Intellectual property attorney Joshua Heslinga on Troutman Sanders’ Virginia IP Law NLRB: Not All Employee Facebook Posts Deserve Protection After All - Hartford lawyer Daniel Schwartz of Pullman & Comley in his Connecticut Employment Law Blog Insight from Other Strategists - Sun Tzu on Terrain - Virginia attorney Andrew Trask of… [read post]
4 Apr 2011, 8:36 pm by Lawrence B. Ebert
Or, as attorney Courtenay Brinckerhoff, a partner with the law firm Foley and Lardner, posed the question in a statement: "Can Myriad explain the difference between patenting isolated DNA and patenting a leaf that has fallen off of a tree?" [read post]
29 Mar 2011, 9:55 pm by Patent Docs
Donald Zuhn of McDonnell Boehnen Hulbert & Berghoff LLP will moderate panel including Courtenay Brinckerhoff of Foley & Lardner LLP and Dr. [read post]
24 Mar 2011, 2:35 am
Of late, Editor Courtenay Brinckerhoff has been discussing patent reform, human antibody claims, license agreements, and "definiteness." [read post]
14 Sep 2010, 10:45 am
Over at PharmaPatents, Courtenay Brinckerhoff has a post "Pharma Cases Dominate New USPTO Obviousness Examination Guidelines." [read post]
8 Jul 2010, 5:00 am by Dennis Crouch
Kappos: Effects on Biotechnology Patents Some New IP Blogs: PharmaPatentsBlog by Courtenay Brinckerhoff and her folks at the Foley law firm. [read post]
2 Oct 2009, 8:21 am
" See Jon Dudas to Foley & Lardner DC office See also the IPBiz posts: Kappos and IBM in May 2009 discussing a panel including Foley & Lardner attorneys Jonathan Spivey, Jon Dudas, Courtenay Brinckerhoff, and Sharon Barner, along with IBM's David Kappos (now USPTO director)IP-Watch on Obama IP insiders [read post]
22 Jun 2009, 12:49 am
" The participants included Foley & Lardner attorneys Jonathan Spivey, Jon Dudas, Courtenay Brinckerhoff, and Sharon Barner, along with IBM's David Kappos, now indicated to be the nominee of Barack Obama for undersecretary at Commerce and Director of the USPTO. [read post]
19 Sep 2007, 5:29 am
Brinckerhoff, Partner, Biotechnology & Pharmaceutical Practice; Stephen P. [read post]
22 Aug 2007, 10:17 am
I spoke with Courtenay Brinckerhoff at Foley & Lardner briefly about the new rules and she expressed the concern that the rule changes may be especially problematic for the chemical, pharmaceutical and biotech arts. [read post]